Income Statement

MARAVAI LIFESCIENCES HOLDINGS, INC.

MRVI
Annual
Performance Overview Click any row in the table to add it to this chart
in millions USD
Metric Dec 31, 2025 2025 FY Dec 31, 2024 2024 FY Dec 31, 2023 2023 FY Dec 31, 2022 2022 FY Dec 31, 2021 2021 FY
Revenue
185.74 259.19 288.95 883.01 799.24
Cost of Revenue
151.75 150.88 148.74 168.96 140.56
Gross Profit
33.99 108.31 140.21 714.05 658.68
Operating Expenses
162.52 180.99 168.67 147.63 115.28
Research & Development
17.40 19.22 17.28 18.37 15.22
Selling, General & Administrative
145.12 161.77 151.39 129.26 100.06
Other Operating Expenses
- - - - -
Operating Income
-128.53 -72.68 -28.47 566.42 543.40
Non-Operating Income
106.44 188.80 -646.20 14.95 12.63
Interest Income
11.44 27.40 27.73 2.34 -
Interest Expense
- - 45.89 20.41 30.26
Other Non-Op Income / Expense
-4.15 -2.34 -1.34 -0.36 0.28
Income Before Tax
-234.97 -261.48 617.74 551.47 530.77
Income Tax Expense
-104.20 -116.64 736.77 331.27 348.73
Non-Controlling Interest
-99.99 -114.78 -19.35 270.46 287.21
Net Income
-130.77 -144.85 -119.03 220.21 182.04
Supplemental Per share data, derived & other items — not part of the income statement
in millions USD unless noted
Metric Dec 31, 2025 2025 FY Dec 31, 2024 2024 FY Dec 31, 2023 2023 FY Dec 31, 2022 2022 FY Dec 31, 2021 2021 FY
Depreciation & Amortization
- - - - -
EBITDA
-128.53 -72.68 -28.47 566.42 543.40
Earnings Per Share (Basic)
-0.90 -1.05 -0.90 1.67 1.59
Diluted EPS
-0.90 -1.05 -0.90 1.67 1.56
Weighted Average Shares
144.36 137.91 131.92 131.55 114.79
Diluted Weighted Avg Shares
144.36 137.91 131.92 255.32 257.80
Comprehensive Income
-130.25 -144.85 -119.03 220.21 182.08